New Publication for the PHAEDRA study (PHAse 2 trial of DuRvalumab in Advanced Endometrial Cancer)
A new journal has been published by the Journal for ImmunoTherapy of Cancer for ANZGOG's PHAEDRA study. The PHAEDRA study examined the activity of the immunotherapeutic agent durvalumab in women with advanced endometrial cancer that [...]